Emerging Nano‐/Microapproaches for Cancer Immunotherapy

Cancer immunotherapy has achieved remarkable clinical efficacy through recent advances such as chimeric antigen receptor‐T cell (CAR‐T) therapy, immune checkpoint blockade (ICB) therapy, and neoantigen vaccines. However, application of immunotherapy in a clinical setting has been limited by low dura...

Descripción completa

Detalles Bibliográficos
Autores principales: Mi, Yu, Hagan, C. Tilden, Vincent, Benjamin G., Wang, Andrew Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425500/
https://www.ncbi.nlm.nih.gov/pubmed/30937265
http://dx.doi.org/10.1002/advs.201801847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425500/
https://www.ncbi.nlm.nih.gov/pubmed/30937265
http://dx.doi.org/10.1002/advs.201801847

Ejemplares similares